Association of Interferon-Based Therapy and Cardiovascular Disease in Chronic Hepatitis C Patients in the United States

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1238
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy of Interferon Combined Glycyrrhizin Therapy in Patients With Chronic Hepatitis C.

Acta Hepatologica Japonica
Hepatology
1994English

Comparison of Adverse Effects Related to Pegylated Interferon-Based Therapy for Patients With Chronic Hepatitis B and Chronic Hepatitis C in Taiwan

Hepatology International
Hepatology
2010English

The Effectiveness of Daclatasvir Based Therapy in European Patients With Chronic Hepatitis C and Advanced Liver Disease

BMC Infectious Diseases
Infectious Diseases
2017English

Outcomes Research in Chronic Viral Hepatitis C: Effects of Interferon Therapy

Canadian Journal of Gastroenterology
2000English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients

Internal Medicine
Internal MedicineMedicine
2011English

Characteristics of Graves’ Disease in a Cohort of Chronic Hepatitis C Patients Treated With Interferon-? And Ribavirin

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2011English

Prevalence of Hepatitis B and Hepatitis C in Patients of Chronic Kidney Disease

International Journal of Research in Medical Sciences
2019English

Interferon Alpha-2b Therapy in Chronic Hepatitis Delta

Hepatitis Monthly
HepatologyInfectious Diseases
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy